Existing Data Sources in Clinical Epidemiology: The Danish COVID-19 Cohort

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus disease 2019 (COVID-19). Situation report - 78, 7 April 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed 717, 2020.
   Google Scholar
• WHO Director-General’s opening remarks at the media briefing on COVID-19-13 March 2020. World Health Organization. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-mission-briefing-on-covid-19---13-march-2020. Accessed July 17, 2020.
   Google Scholar
• COVID-19 - Epidemiologisk overvågningsrapport - den 29. marts 2020. Statens Serum Institut. Available from: https://www.ssi.dk/sygdomme-beredskab-og-forskning/sygdomsovervaagning/c/covid19-overvaagning/arkiv-med-overvaagningsdata-for-covid19. Accessed July 17, 2020
   Google Scholar
• World Health Organization. Landscape of COVID-19 Candidate Vaccines. 2020 Available from: https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1. Accessed 717, 2020.
   Google Scholar
• Flaxman S, Mishra S, Gandy A, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature 2020. doi:10.1038/s41586-020-2405-7.
   Google Scholar
• Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med 2020; 382:1969–1973. doi:10.1056/NEJMp2005630
   Google Scholar
• A Study of a Candidate COVID-19 Vaccine (COV001). ClinicalTrials.gov Identifier: NCT04324606. 3 27, 2020 Available from: https://clinicaltrials.gov/ct2/show/NCT04324606. Accessed 717, 2020.
   Google Scholar
• Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection. ClinicalTrials.gov Identifier: NCT04283461. 2 25, 2020 Available from: https://clinicaltrials.gov/ct2/show/NCT04283461. Accessed 717, 2020
   Google Scholar
• EudraCT Protocol Number: 2020-001200-42. The Impact of Camostat Mesilate on COVID-19 Infection: an investigator-initiated randomized, placebo-controlled, phase IIa trial. 3 24, 2020 Available from: https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001200-42/DK. Accessed 717, 2020
   Google Scholar
• EudraCT Protocol Number: 2020-001052-18. A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults - Version for European Union/United Kingdom Sites. 3 20, 2020 Available from: https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001052-18/DK. Accessed 717, 2020
   Google Scholar
• EudraCT Protocol Number: the NOR Solidarity multicenter trial on the efficacy of different anti-viral drugs in SARS-CoV-2 infected patients (COVID-19). 3 24, 2020 Available from: https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000982-18/NO. Accessed 717, 2020
   Google Scholar
• Ny coronavirus (COVID-19). The Danish Medicines Agency. 4 1, 2020 Available from: https://laegemiddelstyrelsen.dk/da/nyheder/temaer/ny-coronavirus-covid-19/. Accessed 717, 2020
   Google Scholar
• Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 2020;368:m1086. doi:10.1136/bmj.m1086
   Web of Science ®Google Scholar
• EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19. EMA/136850/2020. European Medicines Agency. 3 18, 2020 Available from: https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19. Accessed 717, 2020
   Google Scholar
• Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. doi:10.1016/S2213-2600(20)30116-832171062
   PubMed Web of Science ®Google Scholar
• Kuster GM, Pfister O, Burkard T, et al. SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020;41(19):1801–1803. doi:10.1093/eurheartj/ehaa235
   Google Scholar
• EMA advises continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic. EMA/143324/2020. European Medicines Agency. 3 27, 2020 Available from: https://www.ema.europa.eu/en/news/ema-advises-continued-use-medicines-hypertension-heart-kidney-disease-during-covid-19-pandemic. Accessed 717, 2020
   Google Scholar
• Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591. doi:10.2147/CLEP.S17908331372058
   PubMed Web of Science ®Google Scholar
• Voldstedlund M, Haarh M, Mølbak K, et al. The Danish Microbiology Database (MiBa) 2010 to 2013. Eurosurveillance. 2014;19(1):20667. doi:10.2807/1560-7917.ES2014.19.1.2066724434175
   PubMed Web of Science ®Google Scholar
• Retningslinjer for håndtering af COVID-19 i sundhedsvæsenet. The Danish Health Authority. 3 25, 2020 Available from: https://www.sst.dk/da/Udgivelser/2020/Retningslinjer-for-haandtering-af-COVID-19. Accessed 717, 2020.
   Google Scholar
• Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;449. doi:10.2147/CLEP.S9112526604824
   PubMed Web of Science ®Google Scholar
• Helweg-Larsen K. The Danish register of causes of death. Scand J Public Health. 2011;39(7_suppl):26–29. doi:10.1177/1403494811399958
   PubMed Web of Science ®Google Scholar
• Mors O, Perto GP, Mortensen PB. The Danish Psychiatric Central Research Register. Scand J Public Health. 2011;39(7_suppl):54–57. doi:10.1177/140349481039582521775352
   PubMed Web of Science ®Google Scholar
• Landspatientregisteret moderniseres. The Danish Health Data Authority. 1 17, 2020 https://sundhedsdatastyrelsen.dk/da/registre-og-services/om-de-nationale-sundhedsregistre/sygedomme-laegemidler-og-behandlinger/landspatientregisteret/landspatientregisteret-moderniseres. Accessed 717, 2020.
   Google Scholar
• Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, Sørensen HT, Hallas J, Schmidt M. Data resource profile: the danish national prescription registry. Int J Epidemiol. 2017;46(3):798–798f. doi:10.1093/ije/dyw21327789670
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-324965263
   PubMed Web of Science ®Google Scholar
• Laboratoriedatabasen. The Danish Health Data Authority. Available from: https://sundhedsdatastyrelsen.dk/da/registre-og-services/om-de-nationale-sundhedsregistre/doedsaarsager-og-biologisk-materiale/laboratoriedatabasen. Accessed July 17, 2020
   Google Scholar
• Population in Denmark. Statistics Denmark. https://www.dst.dk/en/Statistik/emner/befolkning-og-valg/befolkning-og-befolkningsfremskrivning/folketal. Accessed July 17, 2020
   Google Scholar
• Reimbursement thresholds. The Danish Medicines Agency. 1 21, 2020 Available from: https://laegemiddelstyrelsen.dk/en/reimbursement/calculate-reimbursement/reimbursement-thresholds/. Accessed 717, 2020
   Google Scholar
• Pottegård A, Kurz X, Moore N, Christiansen CF, Klungel O. Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic. Pharmacoepidemiol Drug Saf 2020. doi:10.1002/pds.5029
   Google Scholar
• Kurz X, Perez-Gutthann S, the ENCePP Steering Group. Strengthening standards, transparency, and collaboration to support medicine evaluation: ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Pharmacoepidemiol Drug Saf. 2018;27(3):245–252. doi:10.1002/pds.438129327451
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147(8):W163–194. doi:10.7326/0003-4819-147-8-200710160-00010-w117938389
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. doi:10.1371/journal.pmed.100188526440803
   PubMed Web of Science ®Google Scholar
• Langan SM, Schmidt SA, Wing K, et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ. 2018:k3532. doi:10.1136/bmj.k3532.30429167
   PubMed Web of Science ®Google Scholar
• Christiansen CF, Møller MH, Nielsen H, Christensen S. The Danish Intensive Care Database. Clin Epidemiol. 2016;8:525–530. doi:10.2147/CLEP.S9947627822095
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, Pearce N. Test-negative designs: differences and commonalities with other case-control studies with “other patient” controls. Epidemiology. 2019;30(6):838–844. doi:10.1097/EDE.0000000000001088
   Google Scholar